A detailed history of Garrett Wealth Advisory Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Garrett Wealth Advisory Group, LLC holds 19,890 shares of PFE stock, worth $493,272. This represents 0.14% of its overall portfolio holdings.

Number of Shares
19,890
Previous 19,852 0.19%
Holding current value
$493,272
Previous $555,000 3.6%
% of portfolio
0.14%
Previous 0.2%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $1,052 - $1,192
38 Added 0.19%
19,890 $575,000
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $18,667 - $21,874
-739 Reduced 3.59%
19,852 $555,000
Q1 2024

Apr 29, 2024

SELL
$25.89 - $29.73 $26,071 - $29,938
-1,007 Reduced 4.66%
20,591 $571,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $564,355 - $733,036
21,598 New
21,598 $621,000
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $165,914 - $216,583
3,974 New
3,974 $203,000
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $604 - $717
13 Added 0.33%
3,946 $207,000
Q1 2022

Apr 25, 2022

SELL
$45.75 - $56.69 $4,483 - $5,555
-98 Reduced 2.43%
3,933 $204,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $166,560 - $246,898
4,031 New
4,031 $238,000
Q4 2019

Jan 28, 2020

SELL
$32.92 - $37.36 $141,424 - $160,498
-4,296 Closed
0 $0
Q3 2019

Oct 18, 2019

BUY
$32.49 - $42.13 $139,577 - $180,990
4,296 New
4,296 $146,000
Q2 2019

Jul 29, 2019

SELL
$36.98 - $41.52 $180,573 - $202,742
-4,883 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$37.5 - $41.2 $5,025 - $5,520
134 Added 2.82%
4,883 $207,000
Q4 2018

Mar 22, 2019

BUY
$38.47 - $43.86 $182,694 - $208,291
4,749 New
4,749 $206,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Garrett Wealth Advisory Group, LLC Portfolio

Follow Garrett Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrett Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrett Wealth Advisory Group, LLC with notifications on news.